UK Innovation Zones

Compare places

Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.

Side by side

DimensionManchesterNorth WestEdinburghScotlandCambridgeEast of England
Sectors

Advanced Materials, Life Sciences, Digital Technologies, Creative Industries

Supporting: Artificial Intelligence, Advanced Manufacturing, Financial Technology, Engineering Biology

Artificial Intelligence, Financial Technology, Robotics & Autonomous Systems, Digital Technologies

Supporting: Engineering Biology, Life Sciences, Quantum Technologies, Creative Industries

Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence

Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies

Research
  • The University of Manchester
  • Manchester Metropolitan University
  • National Graphene Institute
  • Greater Manchester health innovation partnership
  • University of Edinburgh
  • Heriot-Watt University
  • University of Cambridge
  • Wellcome Sanger Institute
  • MRC Laboratory of Molecular Biology
Companies

Not recorded on the map.

  • Edinburgh financial services and fintech cluster
  • Cambridge semiconductor and processor IP cluster
Infrastructure
  • MediaCity
  • Advanced manufacturing Catapult capability, North West

National materials and graphene facilities, teaching hospitals and clinical research capability, and a major broadcast production estate.

  • National Robotarium

Informatics research facilities, robotics commercialisation facilities and supercomputing capability.

  • Babraham Research Campus
  • Cambridge Science Park

University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability.

Capital

A growing regional investor base and northern funds, with growth rounds usually led from London.

Large institutional asset management presence; venture activity is smaller than the capital base implies.

Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand.

Government programmes

No place-based designation recorded.

No place-based designation recorded.

No place-based designation recorded.

What existsAdvanced materials research including graphene and 2D materials, a large health innovation base built on hospitals and universities, a substantial digital and cyber economy, and the biggest broadcast and creative cluster outside London.One of Europe's largest informatics research bases, robotics and autonomous systems commercialisation capability, and a substantial asset management, banking and financial technology sector.Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines.
What's missing · UKIZ interpretationThe step from materials discovery to volume production, and a growth capital base proportionate to the research output. Health data at population scale is under-used by industry.A connection between the capital sitting in Edinburgh's financial institutions and the technology being created a mile away; and later-stage funding to stop companies relocating south.Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth.
What could connect · UKIZ interpretationMaterials research connected to Sheffield and Midlands manufacturing, and health innovation connected to Leeds health data capability — a corridor rather than three separate cities.Scottish institutional capital connected to Scottish deep tech, and Edinburgh AI and robotics capability connected to Glasgow manufacturing and satellite production.Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country.
UKIZ relevanceManchester has scale in four different economies that rarely commission from each other. The proposed zone concentrates on connecting health, materials, digital and creative capability around shared missions.Scotland's research strength is not in question; its scale-up retention is. The proposed Scotland mission focuses on the capital and customer layer.Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford–Cambridge zone concentrates on commercialisation and retention rather than on more discovery.
Last verified15 August 202615 August 202615 August 2026

Proposed by UKIZ · not a government designation